Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

Chicago-based CRISPR technology company Syntax Bio says it has developed tech which automates the slow, manual process of ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...

Mouse embryonic stem cells differentiated into motor neurons after a GFP tag was inserted in frame with the motor-neuron-specific transcription factor HB9, using CRISPR/Cas9 engineering. The Patent ...

Gene therapy could be a permanent cure for many life-threatening hereditary diseases, and this will only help in the treatment of genetic diseases and cancer ...

CRISPR has the power to correct genetic mutations, but current delivery methods are either unsafe or inefficient, keeping the technology from reaching its full medical potential. With the power to ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

A novel gene therapy approach that repairs autologous, long-lasting T cells ex vivo may offer hope to patients with familial hemophagocytic lymphohistiocytosis (FHL), an inherited immune deficiency ...